Overview

BrUOG-PA-209: Lapatinib and Gemcitabine for Metastatic Pancreatic Cancer

Status:
Terminated
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
Phase II study of lapatinib and gemcitabine for patients with metastatic pancreatic cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Brown University
Collaborators:
Memorial Hospital of Rhode Island
Rhode Island Hospital
The Miriam Hospital
Treatments:
Gemcitabine
Lapatinib